BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 8, 2000
View Archived Issues
Sepracor reviews third quarter developments
Read More
Permax approved in Canada as monotherapy for PD
Read More
Aphios awarded grant for antiplaque research
Read More
Amylin moves AC-2993 to phase II for type 2 diabetes
Read More
Phase II trial results for Alprox-TD in ED announced by NexMed
Read More
New three-in-one approach to Parkinson's disease
Read More
SBIR grant awarded to MetaPhore for human septic shock study
Read More
Cistron and Celltech merger approved
Read More
Array BioPharma and Amgen to collaborate on phosphatase inhibitors
Read More
Merger of IGT Pharma and NTB creates new company focused on neuroprotection
Read More
Bayer seeks FDA approval for intravenous formulation of Avelox
Read More
Cilansetron moves into phase III for IBS
Read More
CPMP issues positive opinion for Prevenar
Read More
Maxamine protects against IL-2 toxicity in murine model
Read More
Effective dose range for MK-0663 in RA patients determined in large international trial
Read More
Casodex monotherapy associated with preservation of BMD and sexual interest
Read More
Enzo Biochem's oral HBV protein product highlighted at AASLD meeting
Read More
Preliminary clinical data on parenteral and oral BN-80915 presented at NCI-EORTC-AACR
Read More
Merck issued patent covering new anticoagulants
Read More
Selective factor Xa inhibitors designed by Cor Therapeutics researchers
Read More
Takara Shuzo identifies new anticancer tetrahydrofuran
Read More
Novel immunomodulators claimed by Abbott in patent literature
Read More
Roche's new antidiabetic agents act as glucokinase activators
Read More
New PDE3/4 inhibitors undergo extensive preclinical evaluation at Vernalis
Read More
Peptides from P&G are selective MC3 and/or MC4 receptor ligands
Read More
Neurogen discovers new series of compounds interacting with NK3 and/or GABA-A receptors
Read More
Preparation and use of aP2 inhibitors in diabetes and related conditions
Read More
GST P1-1-activated nitrogen mustard prodrug shows promise as cancer therapy
Read More